Honolulu
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
72- Dermatology
- 54
- Plastic Surgery
- 18
Vendor Review When a Medical Director Is Involved
Medspas operating under physician supervision usually route a new biologics vendor through the supervising physician or a medical director before any product reaches a treatment room, and dermatology and plastic surgery practices tend to follow a similar documentation-first process. The common questions cover donor screening and consent, how long after recovery the tissue is processed, and what third-party testing a lot passes before release.
Donors are mothers who consent to donation at the time of a scheduled, full-term C-section; that donation does not affect a mother's separate option to bank cord blood. Tissue is recovered by trained, licensed personnel and processed within 48 hours.
Account Verification
Every order, regardless of whether it comes from a dermatology practice, a plastic surgery practice, or a medspa, runs through the same NPI verification step to confirm the account sits with an active, licensed physician or a practice operating under one. From there, a practice can request a documentation call covering specifications, processing, and testing records.
Shipping and Storage for This Account Type
Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers and require -80 degree C storage on arrival; lyophilized exosome and Wharton's jelly formats are shelf-stable and are handled according to the insert shipped with the lot. Either format should be logged by lot number at the patient record level once it reaches the practice.
Confirming Fit Before You Order
No exosome product currently has FDA approval, a point FDA has made directly in its own consumer guidance; these products are generally regulated as biologic drugs rather than section 361 tissue products. Whether a Wharton's jelly product's intended use in a given practice qualifies as minimally manipulated and homologous under 21 CFR 1271.10 is for that practice and its counsel to determine.
We recommend the supervising physician confirm standing with the Hawaii Medical Board and that the practice review the regulatory fit with its own legal counsel before adding either product line. These products are not FDA approved or licensed for any disease or condition; this information is written for licensed healthcare professionals and is not medical or legal advice.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Does a Honolulu medspa need its own NPI number, or can it order under the supervising physician's number?+
Accounts are verified against the NPI of the licensed physician who supervises the practice, so a medspa operating under that supervision can be set up under the supervising physician's verified account.
What's the difference in storage requirements between your cryopreserved and lyophilized product lines for a Honolulu practice?+
Cryopreserved formats require -80 degree C freezer storage and arrive on dry ice, while lyophilized formats are shelf-stable at room temperature per the product insert; either can work depending on the practice's storage setup.
Can our practice request the exosome characterization data before deciding whether to add it to our sourcing?+
Yes. Verified accounts can request the supplier's characterization data, such as particle concentration and marker identification, as reference documentation, not as a clinical recommendation.